245 related articles for article (PubMed ID: 21675380)
1. Primary malignant bone tumors--recent developments.
Hameed M; Dorfman H
Semin Diagn Pathol; 2011 Feb; 28(1):86-101. PubMed ID: 21675380
[TBL] [Abstract][Full Text] [Related]
2. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
3. Exosomes in Bone Sarcomas: Key Players in Metastasis.
Chicón-Bosch M; Tirado OM
Cells; 2020 Jan; 9(1):. PubMed ID: 31963599
[TBL] [Abstract][Full Text] [Related]
4. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
[TBL] [Abstract][Full Text] [Related]
5. Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone Tumors.
Kushlinskii NE; Alferov AA; Timofeev YS; Gershtein ES; Bulycheva IV; Bondarev AV; Shchupak MY; Sokolov NY; Polikarpova SB; Efimova MM; Dzampaev AA; Sushentsov EA; Aliev MD; Musaev ER
Bull Exp Biol Med; 2020 Nov; 170(1):64-68. PubMed ID: 33231796
[TBL] [Abstract][Full Text] [Related]
6. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
7. [Cytogenetic and molecular genetic changes in malignant primary bone tumors].
Zoubek A; Kovar H; Gadner H
Radiologe; 1998 Jun; 38(6):467-71. PubMed ID: 9700767
[TBL] [Abstract][Full Text] [Related]
8. Round cell tumors of bone: an update on recent molecular genetic advances.
Wei S; Siegal GP
Adv Anat Pathol; 2014 Sep; 21(5):359-72. PubMed ID: 25105937
[TBL] [Abstract][Full Text] [Related]
9. Diagnoses, treatment, and oncologic outcomes in patients with calcaneal malignances: Case series, systematic literature review, and pooled cohort analysis.
Newman ET; van Rein EAJ; Theyskens N; Ferrone ML; Ready JE; Raskin KA; Lozano Calderon SA
J Surg Oncol; 2020 Dec; 122(8):1731-1746. PubMed ID: 32974945
[TBL] [Abstract][Full Text] [Related]
10. [The role of radiotherapy in the treatment of bone neoplasms].
Koswig S; Budach V
Chirurg; 2002 Dec; 73(12):1174-80. PubMed ID: 12491046
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic and survival trends in adult primary bone tumors of the spine.
Kerr DL; Dial BL; Lazarides AL; Catanzano AA; Lane WO; Blazer DG; Brigman BE; Mendoza-Lattes S; Eward WC; Erickson ME
Spine J; 2019 Dec; 19(12):1941-1949. PubMed ID: 31306757
[TBL] [Abstract][Full Text] [Related]
12. Bone sarcoma incidence in the Netherlands.
Goedhart LM; Ho VKY; Dijkstra PDS; Schreuder HWB; Schaap GR; Ploegmakers JJW; van der Geest ICM; van de Sande MAJ; Bramer JA; Suurmeijer AJH; Jutte PC
Cancer Epidemiol; 2019 Jun; 60():31-38. PubMed ID: 30903831
[TBL] [Abstract][Full Text] [Related]
13. [The combination treatment of malignant bone tumors using fast neutrons].
Chernichenko VA; Tolstopiatov BA; Konovalenko VF; Monich AIu; Palivets AIu
Vopr Onkol; 1990; 36(8):970-3. PubMed ID: 2219842
[TBL] [Abstract][Full Text] [Related]
14. Twenty-year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors.
Xu Y; Shi F; Zhang Y; Yin M; Han X; Feng J; Wang G
Int J Cancer; 2024 Jan; 154(2):226-240. PubMed ID: 37596989
[TBL] [Abstract][Full Text] [Related]
15. Association of extent of local tumor invasion and survival in patients with malignant primary osseous spinal neoplasms from the surveillance, epidemiology, and end results (SEER) database.
Mukherjee D; Chaichana KL; Adogwa O; Gokaslan Z; Aaronson O; Cheng JS; McGirt MJ
World Neurosurg; 2011 Dec; 76(6):580-5. PubMed ID: 22251507
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathology of bone tumours: diagnostic implications.
Puls F; Niblett AJ; Mangham DC
Histopathology; 2014 Mar; 64(4):461-76. PubMed ID: 24428620
[TBL] [Abstract][Full Text] [Related]
17. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
18. Transarticular invasion of iliopelvic sarcomas into the sacrum. Radiological analysis of 47 cases.
Ozaki T; Lindner N; Hillmann A; Link T; Winkelmann W
Acta Orthop Scand; 1997 Aug; 68(4):381-3. PubMed ID: 9310044
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.
Oda Y; Walter H; Radig K; Röse I; Neumann W; Roessner A
J Cancer Res Clin Oncol; 1995; 121(11):667-73. PubMed ID: 7593131
[TBL] [Abstract][Full Text] [Related]
20. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.
Bennani-Baiti IM; Machado I; Llombart-Bosch A; Kovar H
Hum Pathol; 2012 Aug; 43(8):1300-7. PubMed ID: 22245111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
